Dr Emma Rybalka
Honorary Senior Fellow
Department of Medicine
65 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Harmonizing gene nomenclature and disease classification for ADSS1 myopathy
DOI: 10.1186/s13023-026-04535-82026
Journal article
Meeting report on the 2nd clinical and scientific conference on ADSS1 myopathy. 24 October 2025, Boston Children's Hospital, Brookline, Massachusetts, United States of America
DOI: 10.1016/j.nmd.2026.1074642026
Journal article
4.19P Building therapeutic understanding in ADSS1 myopathy through multi-omic disease mapping
DOI: 10.1016/j.nmd.2026.1071962026
Journal article
4.13eP AI-driven drug repurposing for ADSS1 myopathy using cross-cohort skeletal muscle transcriptomic signatures
DOI: 10.1016/j.nmd.2026.1071832026
Conference Proceedings
SP01 Loss of adenylosuccinate synthase (ADSS) isoenzymes impairs neuromuscular development in zebrafish
DOI: 10.1016/j.nmd.2026.1066942026
Journal article
4.14eP Characterization of adenylosuccinate synthase 1 deficiency in mouse models of inherited myopathy
DOI: 10.1016/j.nmd.2026.1071842026
Journal article
WITHDRAWN: Meeting report on the 2nd Clinical and Scientific Conference on ADSS1 myopathy. 24 October 2025, Boston Children’s Hospital, Brookline, Massachusetts, United States of America
DOI: 10.1016/j.nmd.2026.107375
RECENT SCHOLARLY WORKS
2026
Journal article
Multimodal Noninvasive Biomarker Characterization of Structural and Functional Alterations in ADSS1-Deficient Myopathy
DOI: 10.1002/jimd.701932025
Journal article
Considering the potential of ovarian hormones in rescuing neurological phenotypes in Duchenne muscular dystrophy – it's time to think beyond the muscles
DOI: 10.1016/j.mehy.2025.1117662025
Journal article
Repurposed Nrf2 activator dimethyl fumarate rescues muscle inflammation and fibrosis in an aggravated mdx mouse model of Duchenne muscular dystrophy
DOI: 10.1016/j.redox.2025.103676